Antipsychotics and risk of cerebrovascular events in treatment of behavioural and psychological symptoms of dementia in Hong Kong: A hospital-based, retrospective, cohort study

International Journal of Geriatric Psychiatry

Volumn 25, Issue 4, 2010, Pages 362-370

  Chan, Man Chak ^a   Chong, Catherine Shiu Yin ^a   Wu, Anna Ying King ^a   Wong, Kai Choi ^a   Dunn, Eva Lai Wah ^a   Tang, Orlando Wai Nang ^a   Chan, Wah Fat ^a  

^a PAMELA YOUDE NETHERSOLE EASTERN HOSPITAL   (Hong Kong)

Author keywords

Antipsychotics; BPSD; Cerebrovascular event; Dementia; Stroke; Typical atypical antipsychotics

Indexed keywords

AMISULPRIDE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; CHLORPROMAZINE; FLUPENTIXOL; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; SULPIRIDE; THIORIDAZINE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIFLUOPERAZINE;

ADVERSE OUTCOME; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CEREBROVASCULAR ADVERSE EVENT; CEREBROVASCULAR DISEASE; CHINESE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DEMENTIA; DEMOGRAPHY; FEMALE; HAZARD RATIO; HONG KONG; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH SERVICE; MIXED DEPRESSION AND DEMENTIA; MULTIINFARCT DEMENTIA; PRESCRIPTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; STENOSIS; SUBARACHNOID HEMORRHAGE; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK;

AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; CEREBROVASCULAR DISORDERS; DEMENTIA; FEMALE; HONG KONG; HUMANS; INCIDENCE; MALE; RETROSPECTIVE STUDIES; RISK FACTORS; RISPERIDONE;

EID: 77949530870     PISSN: 08856230     EISSN: 10991166     Source Type: Journal    
DOI: 10.1002/gps.2347     Document Type: Article

References (30)

1. Ballard C, Oyebode F. 1995. Psychotic symptoms in patients with dementia. Int J Geriatr Psychiatry 10: 743-752.
2. Ballard C. 2007. Agitation and psychosis in dementia. Am J Geriatr Psychiatry 15: 913-917.
3. Barnett MJ, Wehring H, Perry PJ. 2007. Comparison of risk of cerebrovascular events in an elderly VA population with dementia between antipsychotic and non-antipsychotic users. J Clin Psychopharmacol 27: 595-601.
4. Bewick V, Cheek L, Ball J. 2004. Statistics review 12: Survival analysis. Critical Care 8: 389-394.
5. Brodaty H, Ames D, Snowdon J, et al. 2003. A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia. J Clin Psychiatry 64: 134-143.
6. Douglas IJ, Smeeth L. 2008. Exposure to antipsychotics and risk of stroke: self controlled case series study. BMJ 337: a1227.
7. Finkel S, Kozma C, Long S, et al. 2005. Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics. Int Psychogeriatr 17: 1-13.
8. Gill SS, Rochon PA, Herrmann N, et al. 2005. Atypical antipsychotic drugs and risk of ischemic stroke: population based retrospective cohort study. BMJ 330: 445. doi:10.1136/bmj.38330.470486.8F.
9. Herrmann N, Mamdani M, Lanctot KL. 2004. Atypical antipsychotics and risk of cerebrovascular accidents. Am J Psychiatry 161: 1113-1115.
10. Herrmann N, Lanctot KL. 2005. Do atypical antipsychotics cause stroke? CNS Drugs 19: 91-103.
11. Herrmann N, Lanctot KL. 2006. Atypical antipsychotics for neuropsychiatric symptoms of dementia: Malignant or Maligned? Drug Saf 29: 833-843.
12. International Psychogeriatric Association. 1999. Behavioral and psychological symptoms of dementia educational pack. http://www.ipa-online. org/ipaonlineev3/ipaprograms/bpsdarchives/bpsdrev/toc.asp.
13. Katz IR, Jeste DV, Mintzer JE, et al. 1999. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double-blind trial. J Clin Psychiatry 60: 107-115.
14. Katz I, De Deyn PP, Mintzer J, et al. 2007. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials. Int J Geriatr Psychiatry 22: 475-484.
15. Liperoti R, Gambassi G, Lapane KL, et al. 2005. Cerebrovascular events among elderly nursing home patients treated with conventional or atypical antipsychotics. J Clin Psychiatry 66: 1090-1096.
16. Mackin P, Bishop D, Watkinson H, et al. 2007. Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community. Br J Psychiatry 191: 23-29.
17. Moretti R, Torre P, Antonello RM, et al. 2005. Olanzapine as a possible treatment of behavioral symptoms in vascular dementia: risks of cerebrovascular events: A controlled, open-label study. J Neurol 252: 1186-1193.
18. National Collaborating Centre for Mental Health. 2006. Dementia: Supporting people with dementia and their carers in health and social care. In National Institute for Health and Clinical Excellence clinical guideline 33-39.
19. Newcomer JW. 2007. Metabolic considerations in the use of antipsychotic medications: A review of recent evidence. J Clin Psychiatry 68: 20-27.
20. Percudani M, Barbui C, Fortino I, et al. 2005. Second-generation antipsychotics and risk of cerebrovascular accidents in the elderly. J Clin Psychopharmacol 25: 468-470.
21. Rochon PA, Normand SL, Gomes T, et al. 2008. Antipsychotic therapy and short-term serious events in older adults with dementia. Arch Intern Med 168: 1090-1096.
22. Schneider LS. 1999. Pharmacologic management of psychosis in dementia. J Clin Psychiatry 60: 54-60.
23. Schneider LS, Dagerman K, Philip SI. 2006. Efficacy and adverse effects of atypical antipsychotics for dementia: Meta-analysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry 14: 191-210.
24. Sink KM, Holden KF, Yaffe K. 2005. Pharmacological treatment of neuropsychiatric symptoms of dementia - A review of the evidence. JAMA 293: 596-608.
25. Smith DA, Beier MT. 2004. Association between risperidone treatment and cerebrovascular adverse events: Examining the evidence and postulating hypotheses for an underlying mechanism. J Am Med Dir Assoc 2: 129-132.
26. Valiyeva E, Herrmann N, Rochon PA, et al. 2008. Effect of regulatory warnings on antipsychotic prescription rates among elderly patients with dementia: a population-based time-series analysis. CMAJ 179: 438-446.
27. Wang PS, Schneeweiss S, Setoguchi S, et al. 2007. Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications. J Clin Psychopharmacol 27: 707-710.
28. Whitaker HJ, Farrington CP, Spiessens B, et al. 2006. Tutorial in biostatistics: The self-controlled case series method. Statist Med 25: 1768-1797.
29. Wilcock GK, Ballard CG, Cooper JA, et al. 2008. Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: A pooled analysis of 3 studies. J Clin Psychiatry 69: 341-348.
30. Zomberg GL, Jick H. 2000. Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study. Lancet 356: 1219-1223.